Matthew Keller

Item: Matthew Keller
Rating: 2.47
Author: StockAnalysis.com

Stock Analyst at HC Wainwright & Co.

(2.47)

# 2,443

Out of 4,944 analysts

Total ratings

100%

Success rate

10.3%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Matthew Keller

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ACXP Acurx Pharmaceuticals	Maintains: Buy	$8 → $31	$4.79	+547.86%	1	Aug 12, 2025
	FGEN FibroGen	Maintains: Buy	$10 → $43	$9.41	+356.96%	1	Aug 7, 2025

Acurx Pharmaceuticals

Aug 12, 2025

Maintains: Buy

Price Target: $8 → $31

Current: $4.79

Upside: +547.86%

FibroGen

Aug 7, 2025

Maintains: Buy

Price Target: $10 → $43

Current: $9.41

Upside: +356.96%